Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

Also called NCT01092130

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 101 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01092130
Other papers using this trial's data
  • Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial) American heart journal, 2013-08 DOI, PubMed 23895820

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01092130. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2012-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure
Acronym
VitD-CHF
Condition
Chronic Heart Failure
Intervention (Drug)
Vitamin D
Lead sponsor
University Medical Center Groningen (class: other)
Collaborator
Netherlands Foundation for Cardiovascular Excellence (class: not stated)

Record details

Record id
cardio:ct-nct01092130
Content hash
ad43c36d4e8f1d7ee87757b30954f6cb5949e0810e6a00c4a97d3f6cdffe4134